The main US patent expires next year, and in the meantime BI is looking to move patients over to its newer Spiriva and Spiolto Respimat formulations ... asthma rescue inhaler Airsupra has been ...

Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

Symptoms generally clear up without treatment within 30 minutes. However, it's safer to use a rescue inhaler than wait to see if symptoms will improve without it. Low-intensity activities (e.g., ...

Background Nausea and vomiting is a common ED chief complaint. However, randomised trials comparing antiemetic agents to placebo have not demonstrated superiority. This systematic review investigates ...